No, the two are unrelated. Blood grouping is done and is matched if possible, but Human Leucocyte Antigen (HLA) is more important. The volume of blood transfused is small and ABO (blood type) mismatch is not usually a problem, but there are protocols for preparing ABO mismatched units1.
At present, the odds that a person will have a stem cell transplant for blood or blood related disorder, either from their own cells or from a donor before age 20 are about 1 in 1700, whereas by age 70 the odds are 1 in 200. However, this data does not reflect potential therapies using stem cells that may be developed in the future2.
How can I be assured that CryoSave operates according to the latest quality guidelines?
CryoSave guarantees the highest quality standards in terms of transport, preparation and security of your child’s stored umbilical cord blood and/or cord tissue. All of our Laboratories are appropriately licensed and the Laboratory Protocols have been established in compliance with the NetCord-FACT international guidelines. Geneva’s facility is officially accredited as a Licensed Tissue Establishment for the collection, analysis, processing, cryopreservation, storage and release of stem cells from umbilical cord blood and tissue, and has achieved accreditations according to the highest standards: GMP:WHO, GMP:Pic/S and ISO 9001:2008.